About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6 record(s)
Req # A-2021-10666
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Sanofi Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2020-00811
Provide the specific dollar penalties and total claimed by the PMPRB from the use of excessive prices penalty since 2005 and documentation showing what the money was used for.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-00813
Copies of documents related to the use of the excessive price penalty against Alexion Pharmaceuticals.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2021-00815
Copies of all emails to/from cc'ing Guillaume Coullaird regarding the use of the excessive prices penalty and future use against pharmaceutical companies from January 1, 2019 to January 18, 2021.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2021-01073
Copies of all emails to/from and cc'ing Douglas Clark, Mitchell Levine and Melanie Bourassa-Forcier regarding the decision to delay the implementation of the PMPRB guidelines to Summer 2021 from November 1, 2020 to January 20, 2021.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2021-01083
Copies of all emails to/from and cc'ing Douglas Clark, Mitchell Levine and Melanie Bourassa-Forcier regarding any directives from the Health minister's office regarding the implementation of the new PMPRB guidelines from January 1, 2020 to January 20, 2021.Organization: Patented Medicine Prices Review Board Canada
February 2021